isphere_med on Nostr: The FDA has declined to approve MDMA therapy for PTSD, citing a need for further ...

The FDA has declined to approve MDMA therapy for PTSD, citing a need for further study. MDMA, also known as ecstasy, has shown promise in treating post-traumatic stress disorder. The decision follows a recommendation from the agency's advisory committee earlier this year. While some experts believe that MDMA may offer a breakthrough treatment option, others caution that more research is needed to ensure its safety and efficacy.

Source: https://www.nytimes.com/2024/08/09/health/fda-mdma-ptsd-delay.html